The Ultimate Ex Vivo Lung Perfusion: Xenogeneic Cross-Circulation

The Ultimate Ex Vivo Lung Perfusion: Xenogeneic Cross-Circulation

Xenogeneic cross-circulation is a promising method to recover marginal lungs. It may be more advantageous than EVLP but could introduce risks of zoonotic infections and sensitization to xenoantigens.
Xylyx Bio Awarded $2.2M NIH SBIR Fast-Track Grant from National Heart, Lung, and Blood Institute

Xylyx Bio Awarded $2.2M NIH SBIR Fast-Track Grant from National Heart, Lung, and Blood Institute

Award supports development of a pre-clinical compound testing platform to predict anti-fibrotic drug response
Extracellular Matrix: The Secret Sauce of 3D Cell Culture

Extracellular Matrix: The Secret Sauce of 3D Cell Culture

With 3D cell culture making strong inroads into preclinical studies and basic research, the focus of vendors and investigators alike has turned from discovery to optimization.
XYLYX BIO Launches Specialized Contract R&D Services that Increase Predictiveness in Antifibrotic Drug Discovery

XYLYX BIO Launches Specialized Contract R&D Services that Increase Predictiveness in Antifibrotic Drug Discovery

IN MATRICO™ compound testing services accurately predict in-vivo drug response
Patient-Derived Organoids Transform Precision Medicine

Patient-Derived Organoids Transform Precision Medicine

Advances in cell culture techniques don’t just mean more accurate models, but more personal ones. 
XYLYX BIO Releases Highly Physiologic 2D Substrates for Improved Antifibrotic Drug Discovery

XYLYX BIO Releases Highly Physiologic 2D Substrates for Improved Antifibrotic Drug Discovery

Normal and fibrotic NativeCoat™ ECM substrates increase predictiveness of high throughput compound screening
Damaged Donor Lungs Rescued with Pig Blood

Damaged Donor Lungs Rescued with Pig Blood

Advance could increase the number of suitable organs for transplant
In Astounding Test, Scientists Revive Damaged Lungs for Transplant

In Astounding Test, Scientists Revive Damaged Lungs for Transplant

Injured and unusable lungs were restored with respirators and pig blood.  The procedure one day may increase the supply of organs for transplant.
Xenogeneic Cross-Circulation for Extracorporeal Recovery of Injured Human Lungs

Xenogeneic Cross-Circulation for Extracorporeal Recovery of Injured Human Lungs

Here we demonstrate that acutely injured human lungs declined for transplantation, including a lung that failed to recover on EVLP, can be recovered by cross-circulation of whole blood between explanted human lungs and a Yorkshire...